Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

Bibliographic Details
Main Authors:	Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George F. Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-01-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-024-01739-x

Similar Items

Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine
by: Mengyu Guo, et al.
Published: (2023-12-01)

Manganese-based nanoadjuvants for enhancement of immune effect of DNA vaccines
by: Qiang Ma, et al.
Published: (2022-10-01)

Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal Vaccines
by: Agnieszka Razim, et al.
Published: (2021-03-01)

A Multi‐Functional Nanoadjuvant Coupling Manganese with Toll‐Like 9 Agonist Stimulates Potent Innate and Adaptive Anti‐Tumor Immunity
by: Zhongjie Liu, et al.
Published: (2024-11-01)

Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.
by: Ruiying Wang, et al.
Published: (2024-07-01)

Physicochemical Characterization Cascade of Nanoadjuvant–Antigen Systems for Improving Vaccines
by: Giuditta Guerrini, et al.
Published: (2021-05-01)

Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
by: Yeneng Dai, et al.
Published: (2024-09-01)

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
by: Ki Hyun Bae, et al.
Published: (2024-02-01)

Heterostructural nanoadjuvant CuSe/CoSe₂ for potentiating ferroptosis and photoimmunotherapy through intratumoral blocked lactate efflux
by: Yang, Chunzheng, et al.
Published: (2023)

Fluffy hybrid nanoadjuvants for reversing the imbalance of osteoclastic and osteogenic niches in osteoporosis
by: Guoyang Zhang, et al.
Published: (2024-09-01)

Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine
by: Haoqiang Lai, et al.
Published: (2023-02-01)

Nanoadjuvant-triggered STING activation evokes systemic immunotherapy for repetitive implant-related infections
by: Dongdong Xu, et al.
Published: (2024-05-01)

Recent advances in nanoadjuvant-triggered STING activation for enhanced cancer immunotherapy
by: Zicong Xu, et al.
Published: (2024-10-01)

Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy
by: Li, Jingchao, et al.
Published: (2022)

Synthesis and Optimization of Next-Generation Low-Molecular-Weight Pentablock Copolymer Nanoadjuvants
by: Alaric C. Siddoway, et al.
Published: (2023-10-01)

Iodine-Rich Nanoadjuvants for CT Imaging–Guided Photodynamic Immunotherapy of Breast Cancer
by: Xiaoyan Xin, et al.
Published: (2022-08-01)

Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines
by: Kathleen A. Ross, et al.
Published: (2023-06-01)

In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases
by: Yuan Li, et al.
Published: (2024-09-01)

Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice
by: Chalisa Panapitakkul, et al.
Published: (2022-11-01)

Mitochondria‐Targeted Nanoadjuvants Induced Multi‐Functional Immune‐Microenvironment Remodeling to Sensitize Tumor Radio‐Immunotherapy
by: Zaigang Zhou, et al.
Published: (2024-07-01)

Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques
by: Li Qin, et al.
Published: (2022-11-01)

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
by: Pai Peng, et al.
Published: (2022-11-01)

SPIO Enhance the Cross-Presentation and Migration of DCs and Anionic SPIO Influence the Nanoadjuvant Effects Related to Interleukin-1β
by: Hui Liu, et al.
Published: (2018-12-01)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
by: Eun Kim, et al.
Published: (2023-06-01)

Glutamine supplementation reverses manganese neurotoxicity by eliciting the mitochondrial unfolded protein response
by: Shixuan Zhang, et al.
Published: (2023-07-01)

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
by: Zaigang Zhou, et al.
Published: (2024-09-01)

The adjuvant effect of manganese on tuberculosis subunit vaccine Bfrb-GrpE
by: Shuai Zhou, et al.
Published: (2024-12-01)

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
by: Lilit Grigoryan, et al.
Published: (2022-05-01)

A Delta–Omicron Bivalent Subunit Vaccine Elicited Antibody Responses in Mice against Both Ancestral and Variant Strains of SARS-CoV-2
by: Tiantian Wang, et al.
Published: (2023-09-01)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01)

Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses
by: Chuanyu Liu, et al.
Published: (2024-05-01)

Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
by: Shuxin Guo, et al.
Published: (2023-07-01)

Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
by: Catherine Berry, et al.
Published: (2023-05-01)

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
by: I-Jung Lee, et al.
Published: (2023-12-01)

Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
by: Naru Zhang, et al.
Published: (2022-02-01)

Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
by: Cuiping Liu, et al.
Published: (2023-08-01)

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
by: Tomohiro Takano, et al.
Published: (2023-03-01)

A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination
by: Naveenchandra Suryadevara, et al.
Published: (2022-11-01)

Intranasal Delivery of <i>Quillaja brasiliensis</i> Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice
by: Fernando Silveira, et al.
Published: (2024-08-01)

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
by: Mai Komori, et al.
Published: (2023-05-01)